Avience Biomedicals IPO Live GMP Today

Last GMP recorded

As of 24 Jun 2026, 08:55 pm IST, Avience Biomedicals SME IPO is quoting a grey market premium of +₹107 (+51.4% over the issue price), implying a listing around ₹315 per share.

Current GMP
+107
(+51.4%)
▲ ₹24 vs yesterday
Updated Jun 24, 2026 08:55 pm
Issue Price
₹208
Band: ₹196 - ₹208
Expected Listing
₹315
Based on current GMP
Est. Gain / Lot
+₹1,28,400
+51.4% on listing
₹2,49,600 → ₹3,78,000 (1200 sh)
IPO Details
StatusListed
TypeSME
Open DateJun 18, 2026
Close DateJun 22, 2026
Listing DateJun 25, 2026
Lot Size1200 shares
Issue Size₹30.24 Cr
GMP Trend
GMP History
Date GMP (Rs) Change GMP % Est. Listing
Jun 24, 2026 08:55 pm +107 ▲ 12 +51.4% ₹315
Jun 24, 2026 04:48 pm +95 ▲ 12 +45.7% ₹303
Jun 23, 2026 07:52 pm +83 ▲ 10 +39.9% ₹291
Jun 22, 2026 05:34 pm +73 ▼ 12 +35.1% ₹281
Jun 19, 2026 04:38 pm +85 ▲ 10 +40.9% ₹293
Jun 18, 2026 08:37 am +75 ▲ 1 +36.1% ₹283
Jun 17, 2026 01:55 pm +74 ▲ 11 +35.6% ₹282
Jun 17, 2026 06:34 am +63 ▼ 7 +30.3% ₹271
Jun 16, 2026 11:58 am +70 +33.7% ₹278

Avience Biomedicals IPO GMP — Detailed Analysis

What Avience Biomedicals GMP Tells Us Today

The current Grey Market Premium for Avience Biomedicals IPO is Rs 107 (51.4% over the issue price). Based on this GMP, the implied listing price hovers around Rs 315 per share. Across the 9 GMP records captured for this issue, the trend has been rising by Rs 37 — a useful directional signal for gauging investor sentiment as the listing date approaches.

Avience Biomedicals IPO is expected to list on June 25, 2026.

Avience Biomedicals IPO GMP — FAQs

The current GMP for Avience Biomedicals IPO is Rs 107 (51.4%), indicating an estimated listing price of Rs 315.

Avience Biomedicals IPO is expected to list on June 25, 2026.

The price band for Avience Biomedicals IPO is Rs 196 to Rs 208 per share.

New to grey market data? The hub covers how to read a GMP trend and how SME GMP compares with actual listing performance, and our explainer goes deeper: What is IPO GMP?

GMP (Grey Market Premium) is based on unofficial market activity and does not guarantee listing price. IPO investments are subject to market risk. Please read the offer document before investing.
GMP Update